September 2018
Volume 18, Issue 10
Open Access
Vision Sciences Society Annual Meeting Abstract  |   September 2018
Atomoxetine has no effects on visual working memory but benefits motivation
Author Affiliations
  • Mavis Kusi
    Centre for Neuroscience Studies, Queen's University
  • Lindsey Thurston
    Centre for Neuroscience Studies, Queen's University
  • Catherine Crandell
    Centre for Neuroscience Studies, Queen's University
  • Martin Paré
    Centre for Neuroscience Studies, Queen's University
Journal of Vision September 2018, Vol.18, 689. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mavis Kusi, Lindsey Thurston, Catherine Crandell, Martin Paré; Atomoxetine has no effects on visual working memory but benefits motivation. Journal of Vision 2018;18(10):689.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Atomoxetine (ATX) is a selective catecholamine reuptake inhibitor and is increasingly prescribed to individuals with attention deficit hyperactivity disorder (ADHD). To date, there is equivocal evidence that ATX improves cognitive abilities in nonhuman primates and humans, including people with ADHD. We examined the effects of ATX on visual working memory in three adult female rhesus macaques. The animals were tested with a range of ATX doses (0.03-3 mg/kg) that span beyond the therapeutic range (0.5-1.4 mg/kg); they were orally administered the drug. A visual sequential comparison (VSC) task was used to assess visual working memory. Each trial of the VSC task begins with the presentation of a memory array of 2 to 5 coloured stimuli. Following a one second retention interval, a test array is presented and the animals are required to make a saccade to the item that has changed colour to receive a liquid reward. We found that ATX did not significantly enhance the monkeys' response accuracy and response latency in the VSC task. However, ATX had significant effects on improving the animals' motivation (task engagement) in the VSC task. To more directly assess motivation following the administration of ATX, we developed a task with a progressive ratio (PR) schedule of reinforcement. In this PR task, the animal must fixate a gradually increasing number of visual stimuli to obtain the reinforcer (liquid) and the number of fixations made to obtain the last reinforcer (the breakpoint) estimates motivation. We found that the animals' breakpoint in the PR task varied as a function of ATX dose, with an optimal dose falling within 0.3 and 3 mg/kg. Overall, our results suggest that ATX does not directly enhance visual working memory and may be best described as boosting motivation.

Meeting abstract presented at VSS 2018


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.